AFP AFT Pharmaceuticals Limited
—Mkt Cap: —P/E: —1d ago
AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value290.37M USD
Revenue (TTM)176.02M USD
Gross Profit73.97M USD
Net Income (TTM)10.18M USD
Revenue/Share2.43 AUD
Last Price—
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees126
CountryAU
SectorHealthcare
IndustryDrug Manufacturers - General
ISINNZAFTE0001S4
Valuation
P/E (Trailing)—
P/E (Forward)22.13
PEG—
EV/EBITDA16.90
EV/Revenue1.65
P/S1.48
P/B4.26
EPS (TTM)0.12
EPS (Forward)0.16
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin42.61%
Oper. Margin14.10%
EBITDA Margin9.76%
Profit Margin5.86%
ROE13.36%
ROA6.79%
Growth
Revenue Growth15.20%
Earnings Growth-16.50%
Cash Flow & Leverage
Operating CF-6.59M USD
CapEx (TTM)6.74M USD
FCF Margin-8.23%
FCF Yield—
Net Debt30.32M USD
Net Debt/EBITDA1.76
Balance Sheet
Debt/Equity0.49
Current Ratio2.24
Quick Ratio1.03
Book Value/Sh0.85 AUD
Cash/Share0.10 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.03 AUD
Div. Yield0.37%
5Y Avg Yield—
Payout Ratio8.69%
Ex-Div DateJun 18, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.104.87M
Float30.43M
Insiders77.64%
Institutions1.09%
Technical
SMA 503.615 AUD
SMA 2003.243 AUD
Beta0.47
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)3.64K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—